One of the smaller details of Trumpcare, the redacted version of Obamacare, is the elimination of a tax imposed on manufacturers of medical devices. While the fate of pre-existing conditions has been hogging the spotlight in recent days, this particular tax and its future could have an impact on companies like Ventripoint Diagnostics (OTCMKTS: VPTDF TSE:VPT), and other small cap biotech....More>>>
Employees stand outside the new Amazon Go grocery store in Seattle, Washington, U.S., on Tuesday, Dec. 6, 2016. Amazon.com Inc. unveiled technology that will let shoppers grab groceries without having to scan and pay for them — in one stroke eliminating the checkout line. Photographer: David Ryder/Bloomberg
There’s nothing wrong with profit or efficiency. If you’re in business,....More>>>
Healthcare spending is on track to make up nearly 20% of U.S. GDP by 2025, according to the U.S. Centers for Medicare & Medicaid Services (CMS).
That’s one of the reasons we expect the biotech stock we’re showing you today to double in price by 2020.
Another catalyst for this top biotech stock is the aging baby boomer generation. There are currently 76.5 million....More>>>
Starting with a simple tweet on September 21st, 2015, Hillary Clinton has been pummeling Biotech stocks since her Presidential Campaign first began. In fact, Clinton has caused dramatic drops in the iShares Nasdaq Biotechnology ETF (IBB) at least three times in the past 14 months. The thought of Clinton winning the presidency, and the corresponding assault on the Biotech sector,....More>>>
Its been said of biotech that its the wild west of the investment world. There may be gold in the hills but you better have a good map and a keen eye to find it. One such company that is shimmering of late is Ventripoint Diagnostics (OTC: VPTDF), the Toronto, Ontario based developer of medical devices. With its new cardiac imaging device, the VMS Plus , Ventripoint is changing the way....More>>>
Like most of you, I don’t like to lose money. So you might be wondering why I was so quick to scoop up more shares of Gilead Sciences (NASDAQ:GILD) stock after its latest earnings report. After all, management shared a forecast for 2017 hepatitis C antiviral sales 39% lower than 2016 figures, and that’s at the high end of the provided range.
Before you assume I’ve completely....More>>>
William Patalon III
In a Private Briefing report in late July, we told you that tiny biotech Inovio Pharmaceuticals Inc. (Nasdaq: INO) had dosed its first patient in a Phase I clinical study to evaluate its synthetic vaccine for the Zika virus.
The announcement caught my eye for several reasons…
This is premium content for Private Briefing subscribers only.
Sears Holdings, which wasn’t shy when it announced at the start of the year that it isclosing 150 underperforming stores, has quietly added at least 30more to the list.
Another 12 Sears stores and 18 Kmarts are among the locations that are closing, from Carson, Calif., to Hialeah, Fla., with most scheduled to shut their doorsin July, based on calls to the stores, malls and confirmation....More>>>
U.S. stocks advanced on Thursday, with the main indexes posting their fifth consecutive monthly gain. Meanwhile, a rally in biotech shares pushed the Nasdaq Composite into record territory.
Earlier, a pair of economic reports in the morning that highlighted continued improvement in the economy also boosted sentiment on Wall Street.
The Nasdaq Composite ....More>>>
On Monday, energy stocks soared, pushing the Dow Jones Industrial Average to within almost 180 points of the 20,000 mark. But declines in the financials offset the energy gains and left the industrials short of the mark despite a gain of 0.2% for the Dow.
The S&P 500 fell 0.1%, and the Nasdaq lost 0.6% due to a decline in the financial sector of 0.9% after five sessions in the black.....More>>>